The Clorox Company (CLX) is a Household & Personal Products company in the Consumer Defensive sector, currently trading at $104.44. It has a SharesGrow Score of 66/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CLX = $145.56 (+39.4% from the current price, the stock appears undervalued). Analyst consensus target is CLX = $121 (+15.9% upside).
Valuation: CLX trades at a trailing Price-to-Earnings (P/E) of 17 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.17.
Financials: revenue is $7.1B, +0%/yr average growth. Net income is $810M, growing at +69.8%/yr. Net profit margin is 11.4% (healthy). Gross margin is 45% (+9.2 pp trend).
Balance sheet: total debt is $2.9B against $321M equity (Debt-to-Equity (D/E) ratio 8.97, leveraged). Current ratio is 0.84 (tight liquidity). Debt-to-assets is 51.8%. Total assets: $5.6B.
Analyst outlook: 4 / 28 analysts rate CLX as buy (14%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 80/100 (Pass), Growth 73/100 (Pass), Past 100/100 (Pass), Health 33/100 (Fail), Moat 73/100 (Pass), Future 46/100 (Partial), Income 55/100 (Partial).
